Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Surg Oncol ; 32(10): 1110-3, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16870389

RESUMO

AIMS: Mutations of the E-cadherin gene (CDH1) result in dominantly inherited hereditary diffuse gastric cancer (HDGC). We report a study in the first family diagnosed with HDGC in Spain, examining the presence of mutations in the CDH1 gene. METHODS: The presence of mutations was studied by direct sequencing of all CDH1 exons. Immunohistochemical analysis with specific antibodies was used to detect the expression of E-cadherin in normal and tumour tissue. RESULTS: A novel 1610delC mutation in exon 11 has been found in a Spanish family diagnosed with HDGC. This mutation generates a premature stop codon at position 1667 giving rise to a truncated protein that lacks the transmembrane and beta-catenin-binding domains. The presence of a 1610delC germline mutation was confirmed in three family members diagnosed with diffuse gastric cancer, and also in six asymptomatic members. Of note, the diffuse gastric cancer coexisted with a gastric lymphoma in the proband. Furthermore, immunohistochemical analyses of tumour tissue showed the complete absence of E-cadherin in the proband, revealing a second genetic hit at the CDH1 locus. CONCLUSIONS: We have identified a HDGC family in Spain that carries a novel germline truncating mutation in the CDH1 gene.


Assuntos
Caderinas/genética , Mutação em Linhagem Germinativa , Síndromes Neoplásicas Hereditárias/genética , Neoplasias Gástricas/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD , Caderinas/metabolismo , Triagem de Portadores Genéticos , Humanos , Imuno-Histoquímica , Linfoma/genética , Pessoa de Meia-Idade , Síndromes Neoplásicas Hereditárias/metabolismo , Linhagem , Neoplasias Gástricas/metabolismo
2.
Transplantation ; 64(10): 1383-92, 1997 Nov 27.
Artigo em Inglês | MEDLINE | ID: mdl-9392299

RESUMO

BACKGROUND: To prevent the central role played by complement activation in the hyperacute rejection of pig organs transplanted into primates, pigs transgenic for human decay-accelerating factor (HDAF) have recently been produced. The data presented here extend previous immunohistochemical findings by documenting the immunological characterization and the levels of expression of HDAF in these transgenic pigs. METHODS: Animals from 30 independently derived lines were included in this study. HDAF expression was characterized by immunoprecipitation and epitope mapping. Quantitative analysis was performed by radiometric assays followed by Scatchard analysis and by double-determinant radioimmunoassay. Deposition of iC3b on porcine aortic endothelial cells was determined by radioimmunoassay. DNA slot-blot analysis and densitometric scanning were used to evaluate HDAF transgene copy number. RESULTS: The integrity of HDAF expressed by these transgenic pigs could be demonstrated. HDAF was present in 72% of the organs analyzed, although considerable variation in expression occurred, both between animals and within the same pig. High levels of HDAF on porcine aortic endothelial cells resulted in iC3b deposition at levels as low as that detected on human endothelial cells. Twenty-six organs expressed levels of HDAF greater than those observed in the equivalent human tissue. HDAF expression did not correlate with the number of copies of the transgene incorporated into the porcine genome. CONCLUSIONS: Transgenic pigs, which express levels of functional HDAF even greater than those observed in humans, have successfully been produced. Pigs transgenic for human complement inhibiting molecules could represent a source of organs for future clinical xenotransplantation.


Assuntos
Antígenos CD55/genética , Transplante Heterólogo , Animais , Animais Geneticamente Modificados/genética , Aorta , Biópsia , Antígenos CD55/farmacologia , Ativação do Complemento/imunologia , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Expressão Gênica , Humanos , Técnicas Imunoenzimáticas , Músculos/metabolismo , Músculos/patologia , Radioimunoensaio/métodos , Suínos , Distribuição Tecidual , Transgenes/genética
3.
Mech Ageing Dev ; 93(1-3): 205-14, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9089584

RESUMO

To explore the effects of interleukin-2 (IL-2) treatment in a vaccination protocol in the elderly, we administered low-dose rIL-2 to a group of aged subjects before primary tetanus toxoid immunization. A specific antibody response was detectable in the serum of 6/8 treated individuals after primary immunization, but in only 2/6 untreated controls; following antigenic boosting, specific antibody levels remained relatively unchanged in all the seroconverters. The data were confirmed by studying the ability to produce tetanus-specific antibodies in vitro, and by isoelectrofocusing analysis of serum anti-tetanus antibodies; this latter study showed a more restricted clonal response to the immunogen in untreated individuals. On the other hand, the study of the in vitro proliferative response to tetanus toxoid did not evidence clear differences between the two groups. On the whole, these data seem to indicate that a short-term rIL-2 treatment is able to potentiate the antibody response to tetanus toxoid, and may be a useful tool to improve humoral responses to vaccines in aged subjects.


Assuntos
Linfócitos B/imunologia , Interleucina-2/farmacologia , Toxoide Tetânico/imunologia , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antibacterianos/biossíntese , Anticorpos Antibacterianos/sangue , Formação de Anticorpos/efeitos dos fármacos , Linfócitos B/efeitos dos fármacos , Células Cultivadas , Feminino , Humanos , Imunização Secundária , Ativação Linfocitária/efeitos dos fármacos , Masculino , Proteínas Recombinantes/farmacologia , Fatores de Tempo
5.
Am J Kidney Dis ; 27(6): 784-9, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8651241

RESUMO

Nitric oxide (NO) is a potent endogenous vasodilator and plays a pivotal role in the control of vascular tone by the formation of cyclic guanosine monophosphate (GMP). Patients affected by Bartter's syndrome have lower than normal vascular reactivity with normohypotension and decreased peripheral resistances in spite of biochemical and hormonal abnormalities typical of hypertension, and it is possible that increased production of NO may be involved in maintaining this reduced vascular response and vasodilatation. We have examined this possibility by studying NO2-/NO3- and cyclic GMP urinary excretions to assess NO production in vivo in seven patients affected by Bartter's syndrome compared with seven healthy controls. A group of five patients with hypokalemia other than Bartter syndrome (pseudo-Bartters) was also included in the study to evaluate the effect of hypokalemia on NO production. NO2-/NO3- urinary excretion (0.45 +/- 0.14 v 0.25 +/- 0.04 micromol/micromol urinary creatinine [controls], P < 0.005, v 0.28 +/- 0.05 [pseudo-Bartters], P < 0.01) and cyclic GMP urinary excretion (0.057 +/- 0.028 v 0.022 +/- 0.01 micromol/micromol of urinary creatinine [controls], P < 0.009, v 0.024 +/- 0.004 [pseudo-Bartters], P < 0.02) were increased in patients with Bartter's syndrome in comparison with controls and pseudo-Bartters, and a linear correlation between these two parameters was also present (P < 0.001). We conclude that in Bartter's syndrome the increased NO2-/NO3- and cyclic GMP urinary excretions point to an increased NO synthesis, which could account for the reduced vascular response of the disease, therefore adding its role in determining the vascular hyporeactivity of Bartter's syndrome.


Assuntos
Síndrome de Bartter/fisiopatologia , Síndrome de Bartter/urina , GMP Cíclico/urina , Nitratos/urina , Nitritos/urina , Vasodilatação/fisiologia , Adolescente , Adulto , Creatinina/urina , Feminino , Humanos , Hipopotassemia/fisiopatologia , Hipopotassemia/urina , Masculino , Pessoa de Meia-Idade , Óxido Nítrico/fisiologia , Vasoconstrição/fisiologia
6.
Clin Exp Rheumatol ; 13 Suppl 13: S91-3, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8730485

RESUMO

OBJECTIVE: Hepatitis C virus infection is closely associated not only with hepatic damage, but also with mixed cryoglobulinemia (MC) and other autoimmune and lymphoproliferative disorders. Because HCV is both hepatotropic and lymphotropic, the aim of this study was to investigate whether the genetic background may influence the clinical pattern seen in different patients. METHOD: Two groups of patients with HCV infection were studied: 16 with type II MC and 18 with chronic active hepatitis (CAH). 120 bone marrow donors were considered as the control group. In all patients HLA-A-B-C antigens were evaluated using the microlymphocytoxicity technique, and HLA-DR by the PCR-SSP method. RESULTS: The frequency of the HLA antigens expressed was not precisely defined in the two groups. However, the HLA-B51 and B35 antigens, which are often correlated with autoimmune disorders, were highly expressed in the MC patients (31.2%) compared to the controls (6.9%) and to the CAH group (11%). Moreover, HLA-A9 with its split A24 were present in 50% of the MC patients. More interesting was the expression of the HLA-DR7 antigen, which was found only in the CAH group, suggesting that it may influence the specific liver involvement in HCV infections. CONCLUSION: These findings indicate that the HLA system may play an important role in the clinical manifestations of HCV infection.


Assuntos
Crioglobulinemia/genética , Antígenos HLA/genética , Hepacivirus/imunologia , Adulto , Idoso , Crioglobulinemia/imunologia , Crioglobulinemia/virologia , Feminino , Antígenos HLA/biossíntese , Hepatite Crônica/genética , Hepatite Crônica/imunologia , Teste de Histocompatibilidade , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...